EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

MSAT1-1 - Takeda – HAE and pregnancy: navigating the challenges

Friday 31 May, 17:00 PM - 17:30 PM Valencia, Spain
Alicante Sponsored Sessions

Objectives

  • Review World Allergy Organization (WAO)/EAACI guideline recommendations for the broad use of plasma-derived C1 esterase inhibitor (pdC1-INH) in hereditary angioedema (HAE)
  • Evaluate treatment data for pregnant and breastfeeding patients with HAE
  • Illustrate real-world challenges and considerations for managing pregnant and breastfeeding patients with HAE
17:00
Welcome and introduction
17:03
Balancing HAE and pregnancy: treatment recommendations and approaches
17:13
From theory to practice: managing HAE and pregnancy
17:28

Chairs

Speakers